Abstrak
Preeclampsia is a pregnancy-specific disorder characterized by hypertension, proteinuria and edema. Although the etiology of preeclampsia is still unclear, it is believed that the clinical symptoms are the result of alteration in endothelial cell functions. Evidence of endothelial dysfunction includes increased sensitivity of endothelial cells to vasoconstrictor agent, increased capillary permeability, and elevation of soluble adhesion molecules levels. 1, 2, 3 In recent years, a number of molecules, which mediate leukocyte-endothelial adhesion have been identified, these include E-selectin, and vascular cell adhesion molecule-1 (VCAM-1). The expression of VCAM-1 is induced by cytokine or bacterial endotoxin.
It is believed that oxidative stress also lead to increase expression of VCAM-1 on endothelial cells in preeclampsia. 3 Several adhesion molecules also exist in soluble isoforms. Cell activation involves a more rapid shedding of adhesion molecules from the cell surface. Elevated serum levels of soluble adhesion molecules might be a useful way to monitor the disease activity. Recent studies have demonstrated that serum levels of VCAMs is increased in preeclampsia. 4 Vascular endothelial growth factor (VEGF) is a specific mitogen and survival factor for endothelial cells, and locally initiates permeabilization of blood vessels, extravasation of plasma protein and facilitates angiogenesis. 5, 6 It is believed that placental hypoxia leads to elevation of VEGF and mediates endothelial cell activation in preeclampsia. 6, 7 Serum VEGF is elevated in preeclampsia and is correlated with the severity of the disease. It is assumed that the elevation of VEGF is due to placental hypoxia and mediates endothelial function of preeclampsia. 7, 8 VEGF also promotes the inflammatory process by causing vascular leakage and mobilizing leucocyte. 6 It is not clear whether VEGF will induce sVCAM-1 production by endothelial cell in preeclampsia.
The purpose of this study was to investigate the correlation between VEGF levels in serum preeclampsia and sVCAM-1 production by endothelial cells in culture (HUVEC) when exposed to serum of women with preeclampsia.
METHODS

Subjects
Twelve women with preeclampsia and 11 women with normal pregnancy as control between the ages of 20-35 years were recruited from the Budi Kemuliaan Maternity Hospital in Jakarta. Preeclampsia was defined by the following criteria: hypertension (>140/90 mmHg, or an increase of 30 mmHg systolic or 15 mmHg diastolic blood pressure compared with value obtained before 20 weeks gestation), proteinuria or edema of at least +2. The control group consists of healthy pregnant women, and matched with the preeclampsia group for age, gestational age and parity. All of subjects were recruited to the study on the basis of fully informed consent. Blood samples were collected and allowed to coagulate and then centrifuged at 1500 g for 15 minutes. The serum was stored at -20 C until used.
Endothelial cell culture
Endothelial cells from human umbilical vein were isolated and cultured using the method described by Jaffe. 9 The neonates were at term, of normal birth, with no intrapartum infection, and having clear amniotic fluid. Harvested cells were divided into two equal parts and each seeded into 4 wells of multidish culture (Nunc Corporation, Denmark) in M199 containing 20% fetal calf serum (FCS, Gibco Laboratories, USA), antibiotic and anti fungal preparation. After reaching 80% confluence, the cells were washed with phosphate buffer saline (PBS) and then 3 wells were given either 1 ml M199 phenol red free containing 20% preeclamptic serum or 20% control serum. Well number 4 was reserved for the control (blank). The cells were then incubated at 37C and 5% CO 2 for 24 hours. The supernatant was collected and stored at -80C, while the cells were harvested and counted by a hemocytometer.
VEGF measurement
Preeclamptic and control serum were diluted with M199 media to reach 20% concentration, and used to induced sVCAM production by endothelial cells. CytElisa Human VEGF kit (ams Biotechnology, UK) was used for measuring VEGF concentration. Mouse monoclonal antibodies generated against human VEGF were used to capture human VEGF in sample. Simultaneously, biotinylated rabbit anti-human VEGF polyclonal antibodies were used to detect VEGF in the sample. The assay was visualized using a streptavidin alkaline phosphatase conjugate and an ensuing chromagenic substrate reaction (deep red), which absorb light at 490 nm. The sensitivity of this assay was 18.6 pg/ml, inter-assay variation was 11.1%, and intra-assay variation was 8.9%.
VCAM assay
The concentration of sVCAM-1 in the supernatant of the endothelial cell culture was measured by a sandwich enzyme linked immunoassay. A monoclonal antibody specific for VCAM-1 was coated onto the wells of the microtitre. The samples were pipetted onto the wells, and then biotinylated monoclonal antibody specific for VCAM-1 was added and incubated for 1 hour at room temperature. After washing, streptavidin-peroxidase was added. It was the incubated again for 30 minutes at room temperature and finally chromogen TMB added and color was allowed to develop for 10-15 minutes. After adding H 2 SO 4 and it was read with absorbance at 450 nm. The sensitivity of the assay was 0.9 ng/ml, interassay was 5.2% and intra-assay was 3.1%.
Statistical analysis
Mean 20%VEGF serum level and sVCAM-1 production by endothelial cells culture were calculated. Differences in serum VEGF and s-VCAM concentrations of the supernatant between the groups were analyzed using Student's t test at p<0.05. The correlation between 20%VEGF serum levels and sVCAM-1 production by endothelial cells was determined with Pearson test.
RESULTS
The concentration of VEGF in serum of preeclamptic patients tended to be higher than in normal pregnancy (33.19 + 0.87 pg/ml versus 32.62 + 0.63 pg/ml), but the difference was not significant. sVCAM production by endothelial cells exposed to preeclamptic sera was significantly higher than cells exposed to serum from normal pregnancy (1.326 + 0.745 ng/ml versus 0.755 + 0.415 ng/ml), p<0.05 and t=2.30). No correlation was found between concentration of VEGF in the serum and sVCAM-1 production in the endothelial cell in culture.
Although the levels of VEGF in serum preeclamptic women was higher than in serum from normal pregnancy, and sVCAM-1 production by EC exposed to the preeclamptic sera was also higher than in normal pregnancy, no correlation was found between concentration of VEGF in the serum and concentration of sVCAM-1 produced.
DISCUSSION
Hypoxia is involved in the synthesis of both VEGF and VCAM. Hypoxia also increased leucocyte adhesion to endothelium. In preeclampsia is believed that oxidative stress occurs and lead to hypoxia. Elevated serum levels of soluble adhesion molecules may be useful monitors of disease activity. In this study have demonstrated that concentration of VCAMs production is increased in preeclampsia, but we failure to got correlation of VEGF and sVCAM-1 production. The other study reported that VEGF stimulated expression VCAM-1 in endothelial cell 10 Maybe the VEGF concentration in preeclamptic serum is not to high and many factors in the preeclamptic sera involved production of molecule adhesion. 
